News

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.
BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...
Tandem Diabetes Care shared that its Capillary Biomedical (CapBio) subsidiary won FDA 510(k) clearance for a new infusion set.